Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies

investors.com/news/technology/sarepta-stock-patient-death-gene-therapy-restructuring

Sarepta stock crashed Friday — wiping out all of its restructuring-tied gains — after a third recipient of one of its gene therapies died.
The post Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-07-18 13:06:25.
The Entire Business World on a Single Page. Free to Use →